141 related articles for article (PubMed ID: 18633224)
1. [Involvement of zinc in taste disturbance occurring during treatment for malignant tumor in the chest and the effects of polaprezinc oral disintegrating tablets (a retrospective study)].
Nakata Y; Hirashima T; Kondou Y; Tokuoka Y; Imazato H; Iwata K; Oomori Y; Yamato A; Shimizu S; Nagao S; Matsui K; Abe N
Gan To Kagaku Ryoho; 2008 Jun; 35(6):955-9. PubMed ID: 18633224
[TBL] [Abstract][Full Text] [Related]
2. Effects of polaprezinc on morphological change of the tongue in zinc-deficient rats.
Kinomoto T; Sawada M; Ohnishi Y; Yamaguchi T; Tsuge S; Ogawa S; Washizuka M; Minaguchi J; Mera Y; Takehana K
J Oral Pathol Med; 2010 Sep; 39(8):617-23. PubMed ID: 21054547
[TBL] [Abstract][Full Text] [Related]
3. [The Effectiveness of Polaprezinc Preparation for Taste Alteration in Cancer Chemotherapy].
Mizukami Y; Sato J; Nihei S; Kashiwaba M; Kudo K; Okuyama H; Tamura K
Gan To Kagaku Ryoho; 2016 Aug; 43(8):979-83. PubMed ID: 27539040
[TBL] [Abstract][Full Text] [Related]
4. Preparation and clinical evaluation of a novel lozenge containing polaprezinc, a zinc-L-carnosine, for prevention of oral mucositis in patients with hematological cancer who received high-dose chemotherapy.
Hayashi H; Kobayashi R; Suzuki A; Yamada Y; Ishida M; Shakui T; Kitagawa J; Hayashi H; Sugiyama T; Takeuchi H; Tsurumi H; Itoh Y
Med Oncol; 2016 Aug; 33(8):91. PubMed ID: 27418192
[TBL] [Abstract][Full Text] [Related]
5. A zinc-containing compound, Polaprezinc, is effective for patients with taste disorders: randomized, double-blind, placebo-controlled, multi-center study.
Sakagami M; Ikeda M; Tomita H; Ikui A; Aiba T; Takeda N; Inokuchi A; Kurono Y; Nakashima M; Shibasaki Y; Yotsuya O
Acta Otolaryngol; 2009 Oct; 129(10):1115-20. PubMed ID: 19037756
[TBL] [Abstract][Full Text] [Related]
6. [Development of polaprezinc research].
Takei M
Yakugaku Zasshi; 2012; 132(3):271-7. PubMed ID: 22382829
[TBL] [Abstract][Full Text] [Related]
7. [Orally administered polaprezinc significantly improves taste disorders in ovarian cancer patient undergoing chemotherapy].
Nishijima S; Yanase T; Hata Y; Tamura R; Tsuneki I; Tamura M; Kurabayashi T
Gan To Kagaku Ryoho; 2011 Apr; 38(4):689-92. PubMed ID: 21499007
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease.
Himoto T; Hosomi N; Nakai S; Deguchi A; Kinekawa F; Matsuki M; Yachida M; Masaki T; Kurokochi K; Watanabe S; Senda S; Kuriyama S
Scand J Gastroenterol; 2007 Sep; 42(9):1078-87. PubMed ID: 17710674
[TBL] [Abstract][Full Text] [Related]
9. Oral treatment of pressure ulcers with polaprezinc (zinc L-carnosine complex): 8-week open-label trial.
Sakae K; Yanagisawa H
Biol Trace Elem Res; 2014 Jun; 158(3):280-8. PubMed ID: 24691900
[TBL] [Abstract][Full Text] [Related]
10. Improvement of Dysgeusia by Polaprezinc, a Zinc-L-carnosine, in Outpatients Receiving Cancer Chemotherapy.
Fujii H; Hirose C; Ishihara M; Iihara H; Imai H; Tanaka Y; Matsuhashi N; Takahashi T; Yamaguchi K; Yoshida K; Suzuki A
Anticancer Res; 2018 Nov; 38(11):6367-6373. PubMed ID: 30396959
[TBL] [Abstract][Full Text] [Related]
11. Effect of polaprezinc on taste disorders in zinc-deficient rats.
Hamano H; Yoshinaga K; Eta R; Emori Y; Kawasaki D; Iino Y; Sawada M; Kuroda H; Takei M
Biofactors; 2006; 28(3-4):185-93. PubMed ID: 17473379
[TBL] [Abstract][Full Text] [Related]
12. Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancer.
Watanabe T; Ishihara M; Matsuura K; Mizuta K; Itoh Y
Int J Cancer; 2010 Oct; 127(8):1984-90. PubMed ID: 20104529
[TBL] [Abstract][Full Text] [Related]
13. A Review of Zinc-L-Carnosine and Its Positive Effects on Oral Mucositis, Taste Disorders, and Gastrointestinal Disorders.
Hewlings S; Kalman D
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32121367
[TBL] [Abstract][Full Text] [Related]
14. Polaprezinc prevents oral mucositis in patients treated with high-dose chemotherapy followed by hematopoietic stem cell transplantation.
Hayashi H; Kobayashi R; Suzuki A; Ishihara M; Nakamura N; Kitagawa J; Kanemura N; Kasahara S; Kitaichi K; Hara T; Tsurumi H; Moriwaki H; Itoh Y
Anticancer Res; 2014 Dec; 34(12):7271-7. PubMed ID: 25503160
[TBL] [Abstract][Full Text] [Related]
15. Effects of zinc supplementation on serum zinc concentration and ratio of apo/holo-activities of angiotensin converting enzyme in patients with taste impairment.
Takaoka T; Sarukura N; Ueda C; Kitamura Y; Kalubi B; Toda N; Abe K; Yamamoto S; Takeda N
Auris Nasus Larynx; 2010 Apr; 37(2):190-4. PubMed ID: 19716667
[TBL] [Abstract][Full Text] [Related]
16. [Examination of taste threshold and serum zinc level change after chemotherapy].
Asano S; Ueno K; Niitani M; Uemura K; Murakami Y; Sudo T; Hirata E; Suzuki T; Tsutani Y; Narahara H; Kataoka T
Gan To Kagaku Ryoho; 2012 Sep; 39(9):1389-93. PubMed ID: 22996775
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors of recovery with medication in patients with taste disorders.
Nomura Y; Toi T; Ikeda M; Ikeda A; Tanaka M; Oshima T
PLoS One; 2020; 15(10):e0237270. PubMed ID: 33001974
[TBL] [Abstract][Full Text] [Related]
18. Polaprezinc for prevention of oral mucositis in patients receiving chemotherapy followed by hematopoietic stem cell transplantation: A multi-institutional randomized controlled trial.
Kitagawa J; Kobayashi R; Nagata Y; Kasahara S; Ono T; Sawada M; Ohata K; Kato-Hayashi H; Hayashi H; Shimizu M; Itoh Y; Tsurumi H; Suzuki A
Int J Cancer; 2021 Mar; 148(6):1462-1469. PubMed ID: 32984946
[TBL] [Abstract][Full Text] [Related]
19. Oral zinc therapy for zinc deficiency-related telogen effluvium.
Karashima T; Tsuruta D; Hamada T; Ono F; Ishii N; Abe T; Ohyama B; Nakama T; Dainichi T; Hashimoto T
Dermatol Ther; 2012; 25(2):210-3. PubMed ID: 22741940
[TBL] [Abstract][Full Text] [Related]
20. Zinc-L-Carnosine Complex (Polaprezinc) for the Treatment of Binge Eating: Three Case Reports.
Sakae K; Yanagisawa H
J Clin Psychopharmacol; 2017 Dec; 37(6):734-736. PubMed ID: 28926352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
